and DNDN does 90m @ 50% COGS
Hey #$%$ that was for 12 days of sales. Hold your DNDN like all the other fools that have posted here while MDVN rose 700%.
In the drug’s first 12 days of sales, the drug, Xtandi, generated revenue of $14 million. What’s more, Medivation’s sales partner Astellas Pharma predicted the treatment will produce sales of $100 million by the end of March 2013.
thats still a bit short of DNDN revenue @ 360m